𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma

✍ Scribed by M. Apiranthitou-Drogari; C. Paganin; S. Bernasconi; G. Losa; A. Maneo; N. Colombo; A. Mantovani; P. Allavena

Publisher
Springer-Verlag
Year
1992
Tongue
English
Weight
775 KB
Volume
35
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Distribution of autologous tumor-specifi
Distribution of autologous tumor-specific cytotoxic T lymphocytes in human metastatic melanoma
✍ K. Itoh; M. A. Salmeron; T. Morita; D. Seito; P. P. Mansfield; M. I. Ross; C. M. πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 French βš– 719 KB

The study of specific immunity in human cancers has been hampered by the elusive distribution and heterogeneity of effector cells. In this study, we have investigated the distribution of autologous melanoma-specific cytotoxic T lymphocytes (CTLs) in 18 different distant metastases from melanomas (9

Effects of HC antibody in autologous tum
Effects of HC antibody in autologous tumor-specific cytotoxicity by human melanoma tumor-infiltrating lymphocytes
✍ Paul F. Mansfield; Marie A. Salmeron; Michael G. Rosenblum; Kyogo Itoh πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 689 KB

## Abstract Heteroconjugate (HC) antibody has a potential use in cancer biotherapy because of its ability to mimic antigenic specificity and induce cytotoxicity in the activated lymphocytes against various tumor cells. This study investigated the effects of HC antibody (anti‐CD3 MAb x anti‐p97 mela

Selective infiltration of CCR5+CXCR3+ T
Selective infiltration of CCR5+CXCR3+ T lymphocytes in human colorectal carcinoma
✍ Hiroaki Musha; Haruo Ohtani; Takayuki Mizoi; Makoto Kinouchi; Takashi Nakayama; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 554 KB

## Abstract T cell infiltration in colorectal cancer is associated with a favorable prognosis, suggesting an occurrence of a certain degree of anti‐tumor immunity. T helper type 1 (Th1) and Th2 cells are now known to selectively express CC‐chemokine receptor 5 (CCR5)/CXC‐chemokine receptor 3 (CXCR3